Stockreport

BRIEF-Heat Biologics Reports Data From Phase 2 Trial Of HS-410 Combined With Bacillus Calmette-Guérin For Treating Non-Muscle Invasive Bladder Cancer [Reuters]

Heat Biologics, Inc.  (HTBX) 
Last heat biologics, inc. earnings: 8/14 07:00 am Check Earnings Report
PDF BRIEF-Heat Biologics Reports Data From Phase 2 Trial Of HS-410 Combined With Bacillus Calmette-Guérin For Treating Non-Muscle Invasive Bladder Cancer | Reuters Reuters S [Read more]